FLEX Study
Fluoxetine/Dextromethorphan in Obsessive-Compulsive and Related Disorders: an Open-Label Crossover Pilot Study

Contact: 650-723-4095 or ocdresearch@stanford.edu for more information.

About

Do you worry: About getting sick, hurting someone, thinking bad thoughts, or not doing things right? About your appearance? About your health?

Are you 18-65 years old?

Are you taking fluoxetine, or not taking medications?

We are actively screening individuals with obsessive compulsive disorder (OCD) and the related disorders body dysmorphic disorder (BDD), illness anxiety disorder (IAD) and somatic symptom disorder (SSD) for our Flex Study (Fluoxetine/Dextromethorphan in Obsessive-Compulsive and Related Disorders: an Open-Label Crossover Pilot Study).

Purpose: To understand whether dextromethorphan, an over-the-counter cough medicine, may bring about improvement in symptoms of OCD and other disorders characterized by recurrent intrusive thoughts when used together with fluoxetine.

Registered on clinicaltrials.gov

Participate

You can participate if:

  • You are between 18-65 years old
  • You have a diagnosis of OCD, body dysmorphic disorder (BDD), illness anxiety disorder (IAD), or somatic symptom disorder (SSD)
  • You are living within California
  • You are taking Fluoxetine or not taking medications
  • You have the capacity to provide informed consent

You cannot participate if:

  • You have a psychiatric or medical condition that makes participation unsafe
  • You are pregnant or nursing female

Duration of Study Involvement

  • If eligible, study participation lasts for eight weeks

Contact Us

Email

Phone